Donovan Jones is an IPO research specialist with 15 years of experience identifying opportunities for IPOs. He focuses on high-growth technology, consumer, and life science companies.

He leads the investing group IPO Edge which offers: actionable information on growth stocks through first look S-1 filings, previews on upcoming IPOs, an IPO calendar for tracking what’s on the horizon, a database of U.S. IPOs, and a guide to IPO investing to walk you through the entire IPO lifecycle - from filing to listing to quiet period and lockup expiration dates. Learn more.

SAVU BIOLIFE4D CorporationStock Price & Overview

Quant Ranking

Analysis

News

Latest Headlines

Biolife4D, bioengineered heart developer, upsizes proposed IPO to $10M

Bioengineered heart developer Biolife4D upsizes proposed IPO to $23M

Bioengineered heart developer Biolife4D adds terms to proposed $15M IPO

BIOLIFE4D Seeks IPO For Artificial Heart Bioprinting Plans

SAVU BIOLIFE4D Corporation
Stock Price & Overview